Core Viewpoint - The recent announcements from two companies, Shuiyang International and Ruoyuchen, have put Meisidike in the spotlight regarding its exclusive distribution agreements in China for its oral beauty product line. Group 1: Company Announcements - Shuiyang International claims to be the exclusive distributor in China but does not specify the duration of the agreement [1] - Ruoyuchen has entered a strategic cooperation with Meisidike, with a contract running from January 1, 2026, to December 31, 2028, including an automatic renewal clause [3] - Ruoyuchen will be the exclusive general agent for Meisidike's oral beauty product line in China, which constitutes approximately 98% of the brand's total volume [3][4] Group 2: Operational Details - Ruoyuchen will have full control over the product line's pricing and distribution in the Chinese market [4] - Shuiyang International's announcement lacks clarity on the expiration date and the scope of the licensed product categories [5][6] - Legal experts note that the lack of specific details in the agreements makes it difficult to assess potential conflicts between the two companies [7] Group 3: Market Position and Performance - Meisidike, a Spanish medical beauty brand, has seen significant growth in China, with its sales reaching 5 billion yuan, accounting for half of the brand's global volume [7][10] - The brand's flagship product, the Brightening Drink, is priced at approximately 459.8 yuan per box, translating to 76.7 yuan per 30ml bottle [8] - Ruoyuchen's recent contract with Meisidike is seen as a strategic move to fill a gap in the high-end market segment, complementing its existing product offerings [11][12]